Severe Drug Shortages and Price Hikes Crisis in Iran

Despite a headline referencing geopolitical tensions, the article details a severe healthcare crisis in Iran characterized by acute medication shortages and drastic price increases. Citizens report that prices for essential drugs, including those for cancer, epilepsy, psychiatric disorders, and organ transplants, have surged by up to 400 percent. Patients face immense difficulties locating medications, often visiting numerous pharmacies daily without success, leading some to resort to black markets or unproven herbal alternatives recommended by pharmacists. The situation is particularly critical for individuals with chronic conditions, where treatment interruptions pose life-threatening risks. For instance, transplant patients risk organ rejection due to the unavailability of specific immunosuppressants, while cancer patients struggle with exorbitant costs for chemotherapy drugs that far exceed their pensions. The crisis is exacerbated by insurance companies' failure to settle payments with pharmacies, forcing many drugs into the free market. Reports from various cities, including Tehran and Gilan, highlight the widespread nature of the issue, affecting both specialized and general medications, as well as diagnostic services, creating a humanitarian emergency for vulnerable populations.